pax-101

  1. Sly Saint

    PaxMedica Plans to Initiate Phase 1B Study for PAX-101 (Suramin) in Patients with Long COVID-19 Syndrome

    Study has been approved by the South African Health Authority for individuals with documented COVID-19 infections who develop debilitating physical and neuropsychiatric symptoms that persist for more than 12 weeks after the viral infection has passed - Enrollment is expected to commence in Q1...
    • Sly Saint
    • Thread
    • 2022 clinical trial long covid pax-101 paxmedica post covid-19 syndrome south africa suramin trial
    • Replies: 21
    • Forum: Long Covid news
Back
Top Bottom